These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30521033)

  • 1. Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.
    Xin H
    Med Mycol; 2019 Aug; 57(6):745-756. PubMed ID: 30521033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Xin H
    Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
    Xin H; Glee P; Adams A; Mohiuddin F; Eberle K
    Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Mouse Models of Disseminated Candida auris Infection.
    Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
    Shukla M; Rohatgi S
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-antigen fusion protein vaccination induces protective immunity against
    Jia K; Zhang Y; Jiang M; Cui M; Wang J; Zhang J; Wang H; Zhao H; Li M; Zou Q; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406065. PubMed ID: 39327639
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: Experimental Mouse Models of Invasive Candidiasis Caused by
    Xin H
    J Cell Immunol; 2022; 4(1):29-33. PubMed ID: 35847345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moonlighting proteins induce protection in a mouse model against Candida species.
    Medrano-Díaz CL; Vega-González A; Ruiz-Baca E; Moreno A; Cuéllar-Cruz M
    Microb Pathog; 2018 Nov; 124():21-29. PubMed ID: 30118801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
    Bär E; Gladiator A; Bastidas S; Roschitzki B; Acha-Orbea H; Oxenius A; LeibundGut-Landmann S
    J Immunol; 2012 Jun; 188(11):5636-43. PubMed ID: 22529294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis.
    Diez A; Arrieta-Aguirre I; Carrano G; Fernandez-de-Larrinoa I; Moragues MD
    Vaccine; 2024 Aug; 42(20):125990. PubMed ID: 38789371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidiasis: a fungal infection--current challenges and progress in prevention and treatment.
    Hani U; Shivakumar HG; Vaghela R; Osmani RA; Shrivastava A
    Infect Disord Drug Targets; 2015; 15(1):42-52. PubMed ID: 25809621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
    Cutler JE; Corti M; Lambert P; Ferris M; Xin H
    PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
    Xin H; Rosario-Colon JA; Eberle K
    mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
    Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
    Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 (TLR4) is the major pattern recognition receptor triggering the protective effect of a
    Honorato L; Bonilla JJA; Valdez AF; Frases S; Araújo GRdS; Sabino ALRdN; da Silva NM; Ribeiro L; Ferreira MdS; Kornetz J; Rodrigues ML; Cunningham I; Gow NAR; Gacser A; Guimarães AJ; Dutra FF; Nimrichter L
    mSphere; 2024 Aug; 9(8):e0046724. PubMed ID: 39037263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response that protects against disseminated candidiasis.
    Han Y; Cutler JE
    Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
    Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.